| Literature DB >> 23396893 |
Rajan Sharma, Yudhishthir Singh Rajput, Bimlesh Mann.
Abstract
Glycomacropeptide (GMP) is a C-terminal part (f 106-169) of kappa-casein which is released in whey during cheese making by the action of chymosin. GMP being a biologically active component has gained much attention in the past decade. It also has unique chemical and functional properties. Many of the biological properties have been ascribed to the carbohydrate moieties attached to the peptide. The unique set of amino acids in GMP makes it a sought-after ingredient with nutraceutical properties. Besides its biological activity, GMP has several interesting techno-functional properties such as wide pH range solubility, emulsifying properties as well as foaming abilities which are shown to be promising for applications in food and nutrition industry. These properties of GMP have given new dimension for the profitable utilization of cheese whey to the dairy industry. A number of protocols for isolation of GMP from cheese whey have been reported. Moreover, its role in detection of sweet/rennet whey adulteration in milk and milk products has also attracted attention of various researchers, and many GMP-specific analytical methods have been proposed. This review discusses the chemico-functional properties of GMP and its role in the detection methods for checking cheese or sweet whey adulteration in milk. Recent concepts used in the isolation of GMP from cheese whey have also been discussed.Entities:
Keywords: Adulteration; Cheese whey; Chemico-functional properties; Glycomacropeptide; 化学-功能特性; 干酪乳清; 掺假; 糖巨肽
Year: 2013 PMID: 23396893 PMCID: PMC3567326 DOI: 10.1007/s13594-012-0095-0
Source DB: PubMed Journal: Dairy Sci Technol ISSN: 1958-5586
Fig. 1Primary structure of bovine GMP variant A. The enclosed amino acids represent the sites corresponding to B variant (Eigel et al. 1984)
Role of carbohydrate moiety and peptide backbone in various biological properties of GMP
| Biological properties | Role of carbohydrate moiety | Role of peptide backbone | References |
|---|---|---|---|
| Reduction of gastric secretion | ✓ | Aleinik et al. ( | |
| Bifido-factor | ✓ | Azuma et al. ( | |
| Anti-cariogenic effect | ✓ | Neeser et al. ( | |
| Inhibition of cholera toxin | ✓ | Kawasaki et al. ( | |
| Modulation of immune response | ✓ | ✓ | Otani et al. ( |
| Hemagglutination inhibition | ✓ | Kawasaki et al. ( | |
| Stimulation of cholecystokinin release | ✓ | ✓ | Beucher et al. ( |
| Prevention of intestinal infection | ✓ | Nakajima et al. ( | |
| Nutritional management of phenylketonuria | ✓ | LaClair et al. ( | |
| Antibacterial and probacterial activity of pepsin-treated GMP | ✓ | Robitaille et al. ( |
Chronological order of isolation, biological properties, and functional properties used by various workers for GMP
| Year | Isolation techniques | Biological properties | Functional properties |
|---|---|---|---|
| 1970–1980 | – IEC (Burton and Skudder | – Bifido-factor (György et al. – Inhibition of gastric secretion (Vasilevskaya et al. | – Gelation (Burton and Skudder |
| 1980–1990 | – Gel filtration, IEC, and AC (Morr and Seo | – Anti-cariogenic (Neeser et al. – Modulation of immune system (Otani and Monnai | – Emulsification (Chobert et al. |
| 1990–2000 | – Alcohol precipitation and AC (Saito et al. – UF (Kawasaki et al. – TCA precipitation (Lieske and Konrad – IEC (Tanimoto et al. – Gel chromatography (Nakano and Ozimek | – Inhibition of cholera toxin binding (Kawasaki et al. | – Overrun (Marshall |
| 2000–2010 | – HIC (Silva-Hernandez et al. – Enzyme cross-linking (Tolkach and Kulozik – MAC (Kreuß and Kulozik – ATPS (da Silva et al. | – Prevention of intestinal infection (Nakajima et al. – Nutritional management of phenylketonuria (LaClair et al. | – Interfacial behavior studies (Kreuß et al. – Emulsification (Martin-Diana et al. – Gelation (Farías et al. |
| 2010 onwards | – UF (Robitaille et al. | – Antibacterial and probacterial activity of pepsin-treated GMP (Robitaille et al. | – Foaming properties of GMP-β-lg mixed systems (Martinez et al. |
IEC ion exchange chromatography, AC affinity chromatography, UF ultrafiltration, TCA trichloroacetic acid, HIC hydrophobic interaction chromatography, ATPS aqueous two-phase systems, MAC membrane adsorption chromatography
Fig. 2Role of glycosylation on GMP self-assembly and foaming property a adsorption of aGMP and gGMP at hydrophobic/hydrophilic interface. aGMP can make a stable layer at the interface while in gGMP glycan chains create repulsive forces; b a model to explain the pH-dependent self-assembly of GMP. Below pH 4.5, glycan chains provide a negative charge for gel formation. Adapted from Kreuß et al. (2009b) and Farías et al. (2010). (Figures used with permission)
Comparison of various GMP-based detection methods
| Methods | TCA pre-treatment | Limit of detection | Merits | Demerits | References |
|---|---|---|---|---|---|
| Colorimetric method | ✓ | 5–10%a | No expensive equipment required | Less specificity, low detection limit | Koning et al. ( |
| Fluorimetric method | ✓ | 5%a | Specific to sialic acid | Expensive equipment | Neelima et al. ( |
| Chromatographic method | – | Specificity, convenience | Co-eluting compounds may lead to false-positive results | Kawakami et al. ( | |
| Immunological methods | |||||
| | ✓ | 0.047%a | Easy to use, short assay time, rapid analysis of large number of samples | Even traces of κ-CN can lead to false-positive results | Chávez et al. (2012) |
| | ✓ | 0.5%a | High specificity of immunoblot | Even traces of κ-CN can lead to false-positive results, long procedure time, skilled personnel required | Chávez et al. ( |
| | ✓ | 1%a | Low cost, suitable for routine analysis | Even traces of κ-CN can lead to false-positive results | Martín-Hernández et al. ( |
| SDS–PAGE | ✓ | 1%a | Gives fairly accurate results | Long procedure time, low specificity, skilled personnel required | Galindo-Amaya et al. ( |
| Capillary electrophoresis | – | – | High efficiency and resolution, low solvent consumption, short analysis time | Interference due to proteolysis in stored milk and difficulty in interpretation of results | Recio et al. ( |
| Biosensors | ✓ | 1%b | Specific, robust analytical tool | Expensive equipment required | Haasnoot et al. ( |
aLimit of detection is expressed as presence of cheese whey in milk (v/v)
bLimit of detection is expressed as presence of whey solids in milk (w/w)